NCT03503799 2026-04-13
RESCUE
North Eastern German Society of Gynaecological Oncology
Active not recruiting
Clinical Trials
19 trialsNCT06745024 2026-04-08
Comparing Radiation Therapy to Usual Treatment for Patients With High-Risk Bone Metastases That Are Not Causing Pain, PREEMPT Trial
NRG Oncology
Phase 3 Active not recruiting
NCT03059485 2026-02-04
DC/AML Fusion Cell Vaccine vs Observation in Patients Who Achieve a Chemotherapy-induced Remission
Beth Israel Deaconess Medical Center
Phase 2 Active not recruiting
NCT02492607 2026-01-26
LORD
The Netherlands Cancer Institute
Phase NA Active not recruiting
NCT02870907 2026-01-07
RB SFCE 09
Institut Curie
Phase 2 Active not recruiting
NCT00165256 2025-12-29
Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast
Dana-Farber Cancer Institute
Phase 2 Active not recruiting
NCT07239544 2025-11-20
Generation of Reactive T Cells Based on Tumor Whole Cell Antigen Nanovaccines
The First Affiliated Hospital of Soochow University
Active not recruiting
NCT04519879 2025-10-29
White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA
City of Hope Medical Center
Phase 2 Active not recruiting
NCT03721341 2025-09-18
SABR-COMET 10
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 3 Active not recruiting
NCT04068103 2025-05-07
Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery
NRG Oncology
Phase 2/3 Active not recruiting
NCT06014580 2025-03-07
MADONNA
Latin American Cooperative Oncology Group
Active not recruiting
NCT06728631 2025-02-24
Candonilimab and ATRA Acid for Prevention of Oral Cancer Recurrence in Patients With OPL
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2 Active not recruiting
NCT05857397 2025-02-12
CONOR
Latin American Cooperative Oncology Group
Active not recruiting
NCT00877214 2024-08-22
MAINTAIN
University of Giessen
Phase 3 Active not recruiting
NCT04085250 2024-04-23
Study of Nivolumab for Non-Small Cell Lung Cancer (Stage III) Following Neoadjuvant Chemotherapy Plus Nivolumab and Definitive Concurrent Chemoradiation Therapy
Sun Yat-sen University
Phase 2 Active not recruiting
NCT03469674 2023-10-11
PORTEC-4a
Leiden University Medical Center
Phase 3 Active not recruiting
NCT05730647 2023-02-16
GIM 23- POSTER
Consorzio Oncotech
Active not recruiting
NCT04024475 2022-06-08
Prostate Cancer Biobank
Swiss Cancer Institute
Active not recruiting
NCT02113384 2021-07-28
LARC-EX
Oslo University Hospital
Active not recruiting